Oncology Alliance Launches Multicancer Early Detection Biobank Study
The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Cancer |
The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.
Read MorePosted by Andy Lundin | Jul 20, 2022 | Cancer |
A key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of RNA biomarkers for cancer detection.
Read MorePosted by Andy Lundin | Jul 18, 2022 | Cancer |
A research lab reported using chaperonin as a new marker for cancer cells in blood that provides a clearer indication of spreading cancer.
Read MorePosted by Chris Wolski | Jul 13, 2022 | Lung Cancer |
Researchers have found a blood biomarker that can complement LDCT by distinguishing NSCLC from benign nodules without an invasive biopsy.
Read MorePosted by Andy Lundin | Jul 8, 2022 | Molecular Diagnostics |
BillionToOne announced the launch of its first oncology liquid biopsy products, Northstar Select and Northstar Response.
Read More